A Randomized Trial of Lenient Versus Strict Arm Instruction Post Cardiac Device Surgery
Launched by OTTAWA HEART INSTITUTE RESEARCH CORPORATION · May 31, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how different types of arm restrictions following cardiac device surgery can affect patients' recovery and overall experience. Specifically, the study compares "lenient" instructions, which allow more movement of the arm, to "strict" instructions, which limit arm movement. The goal is to find out if relaxing these restrictions can help patients feel better and reduce the chance of complications after surgery, since many patients receive mixed advice about what they can and cannot do after their procedure.
Anyone who is having surgery to implant a cardiac device that includes at least one new lead may be eligible to participate in this study. Throughout the trial, patients will receive clear instructions about their arm restrictions through both printed materials and phone reminders. The study will also ensure that all patients are monitored for any follow-up care or complications. This research is important because it aims to make the recovery process easier and less stressful for patients after they receive their cardiac devices.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • all patients undergoing device surgery which includes implantation of at least one new endovascular lead
- Exclusion Criteria:
- • Standalone CIED generator replacement
About Ottawa Heart Institute Research Corporation
The Ottawa Heart Institute Research Corporation is a leading clinical research organization dedicated to advancing cardiovascular medicine through innovative research and clinical trials. Affiliated with the renowned University of Ottawa Heart Institute, the corporation focuses on conducting high-quality, ethically-driven studies that aim to improve patient outcomes and enhance understanding of heart-related diseases. With a commitment to collaboration and excellence, the organization engages multidisciplinary teams of researchers, healthcare professionals, and industry partners to translate scientific discoveries into effective therapies and interventions for cardiovascular health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ottawa, Ontario, Canada
Patients applied
Trial Officials
David Birnie
Principal Investigator
Ottawa Heart Institute Research Corporation
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials